ArticleCancer research and treatment2022

Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non-Small Cell Lung Cancer.

Chaelin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.